IL-6 expression also correlates with disease severity in non-alcoholic fatty liver disease (NAFLD) and is higher in nonalcoholic steatohepatitis (NASH) than steatosis alone [11]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.